[The role of new molecular tests in the diagnosis of melanoma in a setting of congenital nævus in an infant].

Apport des nouveaux tests moléculaires dans le diagnostic d’un mélanome sur nævus congénital chez un nourrisson.
5-hydroxymethylcytosine Comparative genomic hybridization Giant congenital nevus H3K27me3 Hybridation génomique comparative Immunohistochemistry Infantile melanoma Mass spectrometry imaging Mélanome Nourrisson Nævus congénital de grande taille Proliferative nodule Spectrométrie de masse nodule de prolifération

Journal

Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 29 09 2019
revised: 14 01 2020
accepted: 10 03 2020
pubmed: 27 5 2020
medline: 16 10 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

Congenital and infantile melanomas are extremely rare. We report a case of a child presenting at birth with a giant congenital nevus complicated by melanoma and on long-term follow-up with exploration using new immunohistochemistry and molecular biology tools. A new-born girl presented at birth with a large congenital cervico-mandibular tumour with para-pharyngeal extension and underlying osteolysis. At 7 months, histology and immunohistochemistry of the operative specimen revealed nodules with atypical features (mitotic figures, necrosis and positive expression of KI67 and P53 in approximatively 50 % of the melanocytic nuclei). A diagnosis was made of infantile melanoma associated with congenital nevi. Repeated surgery and monitoring (clinical and imaging) were performed. At the age of 7 years, as there was no evidence of metastatic lesions, further analyses were performed on the initial operative specimen. Investigation of transcription factor expression using immunohistochemistry, comparative genomic hybridization and histology-guided mass spectrometry, although suspect, did not in itself support a diagnosis of melanoma. Finally, at the age of 7 years, hepatic and pulmonary metastases were reported. Despite combined immunotherapy with ipilimumab and nivolumab, the child died 5 months later. This case illustrates the complexity of diagnosis of infantile melanoma and the risk of metastatic involvement long after the initial diagnosis. Diagnosis may be difficult and necessitates expert advice and the application of several recent methods to reach a conclusion and initiate appropriate treatment.

Identifiants

pubmed: 32451177
pii: S0151-9638(20)30190-3
doi: 10.1016/j.annder.2020.03.006
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Case Reports

Langues

fre

Sous-ensembles de citation

IM

Pagination

746-754

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

M Masson Regnault (M)

Service de dermatologie, centre de références de maladies rares de la peau et des muqueuses, université Paul-Sabatier, hôpital Larrey, CHU de Toulouse, 24, chemin du Pouvourville, 31400 Toulouse, France; Pathology department, Samaritan Drive, San Jose, États-Unis. Electronic address: marie.masson-regnault@chu-poitiers.fr.

S Fraitag (S)

Service d'anatomopathologie, groupe hospitalier Necker-Enfants-Malades, AP-HP, Paris, France.

L Lamant (L)

Service d'anatomopathologie, CHU de Toulouse, Toulouse, France.

A Maza (A)

Service de dermatologie, centre de références de maladies rares de la peau et des muqueuses, université Paul-Sabatier, hôpital Larrey, CHU de Toulouse, 24, chemin du Pouvourville, 31400 Toulouse, France.

A De la Fouchardière (A)

Service d'anatomopathologie, CHU de Lyon, Lyon, France.

E Tournier (E)

Service d'anatomopathologie, CHU de Lyon, Lyon, France.

F Lauwers (F)

Service de chirurgie maxillo-faciale, CHU Purpan, Toulouse, France.

L Carfagna (L)

Service d'oncodermatologie, institut universitaire du Cancer, Toulouse-Oncopole, CHU de Toulouse, Toulouse, France.

N Meyer (N)

Service d'oncodermatologie, institut universitaire du Cancer, Toulouse-Oncopole, CHU de Toulouse, Toulouse, France.

A De Berail (A)

Service de chirurgie maxillo-faciale, CHU Purpan, Toulouse, France.

K J Busam (KJ)

Pathology department, Memorial Sloan-Kettering Cancer Center, New York, États-Unis.

R Lazova (R)

Pathology department, Samaritan Drive, San Jose, États-Unis; Service de dermatologie, hôpital Jean-Bernard, CHU de Poitiers, Poitiers, France.

J Mazereeuw-Hautier (J)

Service de dermatologie, centre de références de maladies rares de la peau et des muqueuses, université Paul-Sabatier, hôpital Larrey, CHU de Toulouse, 24, chemin du Pouvourville, 31400 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH